• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 020983 Product 001 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N020983 001 6161724 Jan 16, 2018 Y
N020983 001 6161724*PED Jul 16, 2018
N020983 001 6170717 Dec 23, 2017 Y
N020983 001 6170717*PED Jun 23, 2018
N020983 001 6315173 Dec 23, 2017 Y
N020983 001 6315173*PED Jun 23, 2018
N020983 001 6431168 Jun 8, 2018 Y
N020983 001 6431168*PED Dec 8, 2018
N020983 001 6435372 Jan 16, 2018 Y
N020983 001 6435372*PED Jul 16, 2018
N020983 001 6510969 Dec 23, 2017 Y
N020983 001 6510969*PED Jun 23, 2018
N020983 001 6558651 Dec 19, 2016 Y U - 716
N020983 001 6558651*PED Jun 19, 2017
N020983 001 6596260 Aug 10, 2014 Y
N020983 001 6596260*PED Feb 10, 2015
N020983 001 6743413 Jun 1, 2021 U - 716
N020983 001 6743413*PED Dec 1, 2021
N020983 001 6938796 Jan 16, 2018 Y
N020983 001 6938796*PED Jul 16, 2018
N020983 001 6966467 Dec 23, 2017 Y
N020983 001 6966467*PED Jun 23, 2018
N020983 001 6997349 Jan 16, 2018 Y
N020983 001 6997349*PED Jul 16, 2018
N020983 001 7107986 Jun 8, 2018 Y
N020983 001 7107986*PED Dec 6, 2018
N020983 001 7143908 Jan 16, 2018 Y
N020983 001 7143908*PED Jul 16, 2018
N020983 001 7350676 Aug 24, 2018 Y
N020983 001 7350676*PED Feb 24, 2019
N020983 001 7500444 Feb 26, 2026 Y
N020983 001 7500444*PED Aug 26, 2026
N020983 001 7832351 Jun 19, 2023 Y
N020983 001 7832351*PED Dec 19, 2023

Exclusivity Data

There is no unexpired exclusivity for this product.


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through August 2014
Patent and Generic Drug Product Data Last Updated September 12, 2014

-
-